LOVE TED W 4

What Happened
Ted W. Love, a director of Jazz Pharmaceuticals plc, was granted 1,527 restricted stock units (RSUs) on February 26, 2026. The grant is reported as an award (code A) at a $0 per-share acquisition price on the Form 4. This is a compensation award to a non-employee director, not an open-market purchase or sale.

These RSUs are subject to service and other conditions and, if they vest, each unit converts into one ordinary share. The grant was made under the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan.

Key Details

• Transaction date: 2026-02-26 (Grant of 1,527 RSUs)
• Reported acquisition price: $0.00 per unit (reporting convention for RSU awards)
• Vesting: Units vest in full on July 24, 2026, subject to the reporting person's continuous service and additional conditions (see footnote).
• Plan: Granted under the Issuer’s 2007 Amended and Restated Non-Employee Directors Stock Award Plan.
• Shares owned after transaction: Not specified in the filing.
• Filing timeliness: Filed 2026-03-02 for a 2026-02-26 transaction — appears timely under Section 16 reporting deadlines.

Context
Restricted stock units are a form of equity compensation representing a contingent right to receive shares upon vesting; they are not an immediate cash investment or sale. Director awards like this are common as part of regular board compensation and do not necessarily signal an independent investment decision by the insider.